AllQuantitative Report
Argus•October 07, 2020
Argus•October 07, 2020ARWR: Raising target price to $55.00
Summary
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, charac
Upgrade to begin using premium research reports and get so much more.
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
UpgradeActions
Download Full ReportRelated Reports
- HALO: Raising target price to $41.00Apr 24, 2024 •
HALO
- CYTK: Lowering target price to $69.00Apr 24, 2024 •
CYTK
- Daily – Vickers Top Buyers & Sellers for 04/18/2024Apr 18, 2024 •
AHH, WDFC, PSTG, ZWS, RXO, IONS, NEOG, CNNE, LBTYK
- HALO: Lowering target price to $40.00Apr 17, 2024 •
HALO
- CYTK: Lowering target price to $72.00Apr 17, 2024 •
CYTK